James A.. Robinson Jr's Net Worth
$250 Thousand
Who is James A.. Robinson Jr?
James A.. Robinson Jr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alkermes plc., Neos Therapeutics, Inc., Urovant Sciences Ltd., APPLIED GENETIC TECHNOLOGIES CORP, UroGen Pharma Ltd., and Eledon Pharmaceuticals, Inc..
SEC CIK
James A.. Robinson Jr's CIK is 0001734295
Past Insider Trading and Trends
2019 was James A.. Robinson Jr's most active year for acquiring shares with 7 total transactions. James A.. Robinson Jr's most active month to acquire stocks was the month of March. 2021 was James A.. Robinson Jr's most active year for disposing of shares, totalling 8 transactions. James A.. Robinson Jr's most active month to dispose stocks was the month of February. 2018 saw James A.. Robinson Jr paying a total of $6,182,400.00 for 165,000 shares, this is the most they've acquired in one year. In 2021 James A.. Robinson Jr cashed out on 1,016,072 shares for a total of $65,970.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alkermes plc. (ALKS) Snapshot price: $26.86
President & COO,Alkermes, Inc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.41K |
$35.89 | -$65,965.82 | 4.41K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -23.45K |
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
∞
| 23.45K |
—
|
—
| 23.45K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
PEO;CEO/Urovant Sciences, Inc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.38K |
—
|
—
|
0
|
Mar 29
| |||
Form 4
| -32.81% | -4.09K |
$16.11 | -$65,970.45 | 8.38K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
∞
| 12.48K |
—
|
—
| 12.48K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APPLIED GENETIC TECHNOLOGIES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
UroGen Pharma Ltd. (URGN) Snapshot price: $13.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||